Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938287289> ?p ?o ?g. }
- W2938287289 endingPage "223" @default.
- W2938287289 startingPage "198" @default.
- W2938287289 abstract "Patients with ischemic stroke or transient ischemic attack and non-valvular atrial fibrillation have a high risk of recurrent stroke and other vascular events. The aim of this guideline is to provide recommendations on antithrombotic medication for secondary prevention of stroke and other vascular outcomes in these patients. The working group identified questions and outcomes, graded evidence, and developed recommendations according to the Grading of Recommendations Assessment, Development, and Evaluation approach and the European Stroke Organisation (ESO) standard operating procedure for guidelines. The guideline was reviewed and approved by the ESO guideline board and the ESO executive committee. In patients with atrial fibrillation and previous stroke or transient ischemic attack, oral anticoagulants reduce the risk of recurrence over antiplatelets or no antithrombotic treatment. Non-vitamin K antagonist oral anticoagulants are preferred over vitamin K antagonists because they have a lower risk of major bleeding and death. Recommendations are weak regarding timing of treatment, (re-)starting oral anticoagulants in patients with previous intracerebral haemorrhage, and treatment in specific patient subgroups of those of older age, with cognitive impairment, renal failure or small vessel disease, because of a lack of strong evidence. In conclusion, for patients with atrial fibrillation and ischemic stroke or transient ischemic attack, non-vitamin K antagonist oral anticoagulants are the preferred treatment for secondary prevention of recurrent stroke or thromboembolism. Further research is required to determine the best timing for initiating oral anticoagulants after an acute ischemic stroke, whether or not oral anticoagulants should be (re)started in patients with a history of intracerebral haemorrhage, and the best secondary preventive treatment in specific subgroups." @default.
- W2938287289 created "2019-04-25" @default.
- W2938287289 creator A5000524196 @default.
- W2938287289 creator A5022472213 @default.
- W2938287289 creator A5044683733 @default.
- W2938287289 creator A5055136959 @default.
- W2938287289 creator A5056951090 @default.
- W2938287289 creator A5061445522 @default.
- W2938287289 creator A5069532705 @default.
- W2938287289 creator A5088937468 @default.
- W2938287289 date "2019-04-09" @default.
- W2938287289 modified "2023-10-14" @default.
- W2938287289 title "Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline" @default.
- W2938287289 cites W10734288 @default.
- W2938287289 cites W132631509 @default.
- W2938287289 cites W1498265361 @default.
- W2938287289 cites W1550111394 @default.
- W2938287289 cites W1555652492 @default.
- W2938287289 cites W1598602811 @default.
- W2938287289 cites W1968737649 @default.
- W2938287289 cites W1971442835 @default.
- W2938287289 cites W1982692879 @default.
- W2938287289 cites W1982764283 @default.
- W2938287289 cites W1987653002 @default.
- W2938287289 cites W1996448745 @default.
- W2938287289 cites W2005257697 @default.
- W2938287289 cites W2025611422 @default.
- W2938287289 cites W2026458612 @default.
- W2938287289 cites W2026766534 @default.
- W2938287289 cites W2030703473 @default.
- W2938287289 cites W2040373874 @default.
- W2938287289 cites W2043351648 @default.
- W2938287289 cites W2044891648 @default.
- W2938287289 cites W2048831659 @default.
- W2938287289 cites W2059193904 @default.
- W2938287289 cites W2064836413 @default.
- W2938287289 cites W2065028337 @default.
- W2938287289 cites W2071376777 @default.
- W2938287289 cites W2078568576 @default.
- W2938287289 cites W2085627909 @default.
- W2938287289 cites W2095647706 @default.
- W2938287289 cites W2097730817 @default.
- W2938287289 cites W2099442549 @default.
- W2938287289 cites W2104901197 @default.
- W2938287289 cites W2108745446 @default.
- W2938287289 cites W2108823833 @default.
- W2938287289 cites W2110258159 @default.
- W2938287289 cites W2112970567 @default.
- W2938287289 cites W2113089341 @default.
- W2938287289 cites W2114775432 @default.
- W2938287289 cites W2115996784 @default.
- W2938287289 cites W2116559262 @default.
- W2938287289 cites W2117220107 @default.
- W2938287289 cites W2117807413 @default.
- W2938287289 cites W2119761759 @default.
- W2938287289 cites W2124693325 @default.
- W2938287289 cites W2129906781 @default.
- W2938287289 cites W2134004558 @default.
- W2938287289 cites W2138775201 @default.
- W2938287289 cites W2145624807 @default.
- W2938287289 cites W2147018083 @default.
- W2938287289 cites W2148984742 @default.
- W2938287289 cites W2149388786 @default.
- W2938287289 cites W2150736083 @default.
- W2938287289 cites W2152623033 @default.
- W2938287289 cites W2157459435 @default.
- W2938287289 cites W2158742097 @default.
- W2938287289 cites W2159193915 @default.
- W2938287289 cites W2159730165 @default.
- W2938287289 cites W2159975225 @default.
- W2938287289 cites W2160038959 @default.
- W2938287289 cites W2162838438 @default.
- W2938287289 cites W2163399076 @default.
- W2938287289 cites W2165168223 @default.
- W2938287289 cites W2292941107 @default.
- W2938287289 cites W2334781704 @default.
- W2938287289 cites W2340635798 @default.
- W2938287289 cites W2340932674 @default.
- W2938287289 cites W2408652178 @default.
- W2938287289 cites W2435343268 @default.
- W2938287289 cites W2472624475 @default.
- W2938287289 cites W2515341923 @default.
- W2938287289 cites W2523455750 @default.
- W2938287289 cites W2526384176 @default.
- W2938287289 cites W2544350519 @default.
- W2938287289 cites W2586934323 @default.
- W2938287289 cites W2587004901 @default.
- W2938287289 cites W2621026111 @default.
- W2938287289 cites W2621231439 @default.
- W2938287289 cites W2622307161 @default.
- W2938287289 cites W2735024370 @default.
- W2938287289 cites W2738888953 @default.
- W2938287289 cites W2752359758 @default.
- W2938287289 cites W2762383991 @default.
- W2938287289 cites W2766540689 @default.
- W2938287289 cites W2767504651 @default.
- W2938287289 cites W2768961483 @default.
- W2938287289 cites W2794283332 @default.